ERBB2 and breast cancer: In clinical practice, breast cancers are classified into five subtypes based on histological and molecular characteristics: tumors expressing ER and/or PR are considered hormone receptor-positive; those lacking ER, PR, and HER2 are triple-negative breast cancers (TNBCs).